港股異動 | 華虹半導體(1347.HK)漲逾5%續創新高 獲機構看好疊加南下資金買入
格隆匯12月3日丨華虹半導體(1347.HK)股價繼續走強,現報43.7港元續創歷史新高,漲幅5.43%,最新總市值566.08億港元,年內累計漲逾140%。數據顯示,該股在昨日獲南下資金淨買入3.31億港元。中信證券指,公司有望受益8英寸晶圓產能吃緊,12英寸晶圓廠擴產有望超預期,認為公司2020年業績處於拐點,後續有望持續向好。小幅上調2020-2022淨利潤預測至0.76/1.23/1.62億美元,給予目標價50.23港元,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.